GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivoCaroline Pabst(European Molecular Biology Organization), Frédéric Barabé(Universitat Autònoma de Barcelona)BloodFebruary 1, 201610.1182/blood-2015-11-683649Cited by 234SaveCiteExport RISWatch citationsRelated PapersVenetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1|Blood|2022|100CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia|EMBO Molecular Medicine|2022|21